DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Junji Tsurutani Kimio Yonesaka |
| Publication date | July 12, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |